mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
2e-07 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-07 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
9e-06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
2e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
8e-05 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
9e-05 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.0001 |